| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/01/2011 | US20110212095 Epitope of cd66c specific to lung adenocarcinoma and antibody recognizing the same |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212093 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| 09/01/2011 | US20110212092 Glucagon receptor antagonists |
| 09/01/2011 | US20110212091 Materials and methods for inhibiting cancer cell invasion |
| 09/01/2011 | US20110212090 Combinatorial Analysis and Repair |
| 09/01/2011 | US20110212089 Targeting pax2 for the treatment of breast cancer |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212086 GITR Antibodies For The Treatment of Cancer |
| 09/01/2011 | US20110212085 Lung cancer disease targets and uses thereof |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease |
| 09/01/2011 | US20110212082 Method for producing tablet comprising natural allicin |
| 09/01/2011 | US20110212081 Krüppel-like factors and fat regulation |
| 09/01/2011 | US20110212080 Urea derivatives as antibacterial agents |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212078 Synthesis and use of heterocyclic antibacterial agents |
| 09/01/2011 | US20110212077 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 09/01/2011 | US20110212076 Viral Therapeutic |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | US20110212023 TADG-15: an extracellular serine protease overexpossed in carcinomas |
| 09/01/2011 | US20110212022 Antitumor antibodies, proteins, and uses thereof |
| 09/01/2011 | CA2791787A1 Recombinant cdv compositions and uses thereof |
| 09/01/2011 | CA2791153A1 Immunogenic proteins and compositions |
| 09/01/2011 | CA2791025A1 Method of inducing the production of protective anti-hiv-1 antibodies |
| 09/01/2011 | CA2790984A1 Combination vaccine for streptococcus |
| 09/01/2011 | CA2790978A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | CA2790895A1 Protein formulations |
| 09/01/2011 | CA2790412A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 09/01/2011 | CA2790219A1 Treatment or prevention of infection |
| 09/01/2011 | CA2790014A1 Fully human anti-vegf monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2790013A1 Fully human anti-tnf-.alpha. monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | CA2789132A1 Antagonist il-7 receptor antibodies to treat type 2 diabetes and immunological disorders |
| 09/01/2011 | CA2789061A1 Stable antibody containing compositions |
| 09/01/2011 | CA2787952A1 Anti-angiogenesis therapy for the treatment of ovarian cancer |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361988A1 Molecular marker for cancer stem cell |
| 08/31/2011 | EP2361982A1 Human gene encoding ubiquitin conjugating enzyme |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361973A2 Production and use of human CD124 and CD116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
| 08/31/2011 | EP2361934A2 Hepatocyte growth factor (HGF) binding proteins |
| 08/31/2011 | EP2361933A2 Antibodies against interleukin-1 beta |
| 08/31/2011 | EP2361932A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 08/31/2011 | EP2361930A2 Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| 08/31/2011 | EP2361928A1 Truncated fragments of alpha-synuclein in Lewy body disease |
| 08/31/2011 | EP2361926A2 Yersinia SSP. polypeptides and methods of use |
| 08/31/2011 | EP2361638A1 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 08/31/2011 | EP2361637A1 Formulation of human antibodies for treating TNF-alpha associated disorders |
| 08/31/2011 | EP2361636A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361634A1 Proteins/peptides having immunogenic properties and their biological applications |
| 08/31/2011 | EP2361633A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 08/31/2011 | EP2361632A1 Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases |
| 08/31/2011 | EP2361629A1 Prevention and treatment of synucleinopathic disease |
| 08/31/2011 | EP2361317A1 Use of eif3m for the diagnosis and treatment of cancer |
| 08/31/2011 | EP2361315A1 Cxcl4l1 as a biomarker of pancreatic cancer |
| 08/31/2011 | EP2361263A1 Use of anti-cs1 antibodies for treatment of rare lymphomas |
| 08/31/2011 | EP2361096A1 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 08/31/2011 | EP2361095A1 Antagonists of il-6 to raise albumin and/or lower crp |
| 08/31/2011 | EP2361094A1 Combination vaccine with whole cell pertussis |
| 08/31/2011 | EP2361085A2 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer |
| 08/31/2011 | EP2054431B1 Conformers of bacterial adhesins |
| 08/31/2011 | EP1625163B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-43 |
| 08/31/2011 | EP1474505B1 Noninvasive genetic immunization by topical application of bacterial vectors |
| 08/31/2011 | EP1446422B1 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | CN102171569A Autoantibodies in the detection and treatment of cancer |
| 08/31/2011 | CN102171340A MELK epitope peptides and vaccines containing the same |
| 08/31/2011 | CN102171334A Method for producing purified influenza virus antigen |
| 08/31/2011 | CN102170910A Novel use application of sugar chain-recognizing receptor |
| 08/31/2011 | CN102170909A Anti-NOTCH2 antibodies and methods of use |
| 08/31/2011 | CN102170908A Delivery of a CD40 agonist to a tumor draining lymph node of a subject |
| 08/31/2011 | CN102170907A Pharmaceutical composition for treatment and prevention of cancer |
| 08/31/2011 | CN102170906A Compositions and methods for antibodies targeting complement protein C5 |
| 08/31/2011 | CN102170905A Therapeutic agent or preventive agent for osteoarthritis |
| 08/31/2011 | CN102170904A Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 08/31/2011 | CN102170903A Products and methods for stimulating an immune response |
| 08/31/2011 | CN102170902A Influenza vaccines |
| 08/31/2011 | CN102170901A Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 08/31/2011 | CN102170900A Novel immunotherapy against several tumors including neuronal and brain tumors |
| 08/31/2011 | CN102170897A Vaccine containing amb a 1 for treating allergy to ragweed |
| 08/31/2011 | CN102169121A New application of human kinase SBK1 (SH3-binding domain kinase 1) |
| 08/31/2011 | CN102168100A Echinococcus granulosusglutathione transferase gene and application thereof |
| 08/31/2011 | CN102168089A Echinococcus granulosus calreticulin gene and application thereof |
| 08/31/2011 | CN102168088A T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine |
| 08/31/2011 | CN102168076A An ubiquitin ligase and the application thereof |
| 08/31/2011 | CN102168073A Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production |
| 08/31/2011 | CN102167745A Human monoclonal antibody against IgE, preparation method and purpose thereof |
| 08/31/2011 | CN102167744A Human anti-CD20 monoclonal antibody and preparation method and application thereof |
| 08/31/2011 | CN102167743A Human monoclonal antibody against EGFR, preparation method and purpose thereof |
| 08/31/2011 | CN102167742A Human monoclonal antibody against HER2, preparation method and purpose thereof |
| 08/31/2011 | CN102167741A Fully human anti-TNF-alpha (Tumor Necrosis Factor-alpha) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167740A Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167735A Recombinant antigen protein of S.japonicum SjTollip and preparation method and application thereof |
| 08/31/2011 | CN102166362A Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof |
| 08/31/2011 | CN102166356A Application of alpha-mannatide as vaccine adjuvant and vaccine preparation prepared using same |
| 08/31/2011 | CN102166355A Quadruple inactivated vaccine for preventing chicken diseases |
| 08/31/2011 | CN102166354A Rabies inactivated vaccine and preparation method thereof |